Agilent Restructures, Laying off 450; Q2 Revenues Flat | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies announced after the close of the market on Tuesday a restructuring program expected to reduce its headcount by about 450 employees and save the company $50 million annually in operating expenses.

The Santa Clara, Calif.-based firm also reported that revenues were flat year over year in its fiscal second quarter and that its board approved an additional $500 million to its existing share buy-back program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.